Predictors of lack of glycemic control in persons with type 2 diabetes
Tóm tắt
Professional guidelines recommend an HbA1c < 7% for most people with diabetes and < 8.5% for those with relaxed glycemic goals. However, many people with type 2 diabetes mellitus (T2DM) are unable to achieve the desired HbA1c goal. This study evaluated factors associated with lack of improvement in HbA1c over 3 years. All patients with T2DM treated within a major academic healthcare system during 2015–2020, who had at least one HbA1c value > 8.5% within 3 years from their last HbA1c were included in analysis. Patients were grouped as improved glycemic control (last HbA1c ≤ 8.5%) or lack of improvement (last HbA1c > 8.5%). Multivariate logistic regression analysis was performed to assess independent predictors of lack of improvement in glycemic control. Out of 2,232 patients who met the inclusion criteria, 1,383 had an improvement in HbA1c while 849 did not. In the fully adjusted model, independent predictors of lack of improvement included: younger age (odds ratio, 0.89 per 1-SD [12 years]; 95% CI, 0.79–1.00), female gender (1.30, 1.08–1.56), presence of hypertension (1.29, 1.08–1.55), belonging to Black race (1.32, 1.04–1.68, White as reference), living in low income area (1.86,1.28–2.68, high income area as reference), and insurance coverage other than Medicare (1.32, 1.05–1.66). Presence of current smoking was associated with a paradoxical improvement in HbA1c (0.69, 0.47—0.99). In a subgroup analysis, comparing those with all subsequent HbA1c values > 8.5% (N = 444) to those with all subsequent HbA1c values < 8.5% (N = 341), similar factors were associated with lack of improvement, but smoking was no longer significant. We conclude that socioeconomic factors like race, type of insurance coverage and living in low-income areas are associated with lack of improvement in HbA1c over a period of 3-years in people with T2DM. Intervention strategies focused on low-income neighborhoods need to be designed to improve diabetes management.
Tài liệu tham khảo
Centers for Disease Control and Prevention, National Diabetes Statistics Report, 2020 Atlanta. GA: U.S. Dept of Health and Human Services; 2020. 2021 [Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html.
UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of Complications in patients with type 2 Diabetes (UKPDS 33). The Lancet. 1998;352(9131):837–53.
Glycemic Targets. Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(Supplement1):83-S96.
Carls G, Huynh J, Tuttle E, Yee J, Edelman SV. Achievement of Glycated Hemoglobin goals in the US remains unchanged through 2014. Diabetes Therapy. 2017;8(4):863–73.
Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. Diabetes Care, 1999–2010. N Engl J Med. 2013;368(17):1613–24.
ADVANCE. Intensive blood glucose control and vascular outcomes in patients with type 2 Diabetes. N Engl J Med. 2008;358(24):2560–72.
ACCORD. Effects of intensive glucose lowering in type 2 Diabetes. N Engl J Med. 2008;358(24):2545–59.
Beltrán S, Arenas DJ, López-Hinojosa IJ, Tung EL, Cronholm PF. Associations of Race, Insurance, and Zip Code-Level income with nonadherence diagnoses in primary and Specialty Diabetes Care. J Am Board Family Med. 2021;34(5):891–7.
Laraia BA, Karter AJ, Warton EM, Schillinger D, Moffet HH, Adler N. Place matters: neighborhood deprivation and cardiometabolic risk factors in the Diabetes Study of Northern California (DISTANCE). Soc Sci Med (1982). 2012;74(7):1082–90.
U.S. Census Bureau. American Community Survey (ACS) [Available from: https://www.census.gov/programs-surveys/acs.
Pantalone KM, Misra-Hebert AD, Hobbs TM, Kong SX, Ji X, Ganguly R, et al. The probability of A1C goal attainment in patients with uncontrolled type 2 Diabetes in a large Integrated Delivery System: a prediction model. Diabetes Care. 2020;43(8):1910–9.
Hirsch AG, Durden TE, Nordberg C, Berger A, Schwartz BS. Associations of Four Community factors with Longitudinal Change in Hemoglobin A1c levels in patients with type 2 Diabetes. Diabetes Care. 2017;41(3):461–8.
Rothenbacher D, Rüter G, Saam S, Brenner H. Younger patients with type 2 Diabetes need better glycaemic control: results of a community-based study describing factors associated with a high HbA1c value. Br J Gen Practice: J Royal Coll Gen Practitioners. 2003;53(490):389–91.
Kautzky-Willer A, Kosi L, Lin J, Mihaljevic R. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 Diabetes: results from patient-level pooled data of six randomized controlled trials. Diabetes Obes Metab. 2015;17(6):533–40.
Sargeant LA, Khaw K-T, Bingham S, Day NE, Luben RN, Oakes S, et al. Cigarette Smoking and glycaemia: the EPIC-Norfolk Study. Int J Epidemiol. 2001;30(3):547–54.
Zhang JX, Huang ES, Drum ML, Kirchhoff AC, Schlichting JA, Schaefer CT, et al. Insurance status and quality of Diabetes care in community health centers. Am J Public Health. 2009;99(4):742–7.
Yan LD, Ali MK, Strombotne KL. Impact of expanded Medicaid Eligibility on the Diabetes continuum of Care among low-income adults: a difference-in-differences analysis. Am J Prev Med. 2021;60(2):189–97.
Kowitt SD, Donahue KE, Fisher EB, Mitchell M, Young LA. How is neighborhood social disorganization associated with Diabetes outcomes? A multilevel investigation of glycemic control and self-reported use of acute or emergency health care services. Clin Diabetes Endocrinol. 2018;4(1):19.